Key result
Extracorporeal use of unfractionated heparin during hemodialysis did not significantly affect hematological parameters, although serum potassium was significantly decreased post-dialysis.
Why the study?
Does extracorporeal unfractionated heparin affect hematological and electrolyte markers in patients undergoing hemodialysis?
Observational (n=50)
No
Does extracorporeal unfractionated heparin affect hematological and electrolyte markers in patients undergoing hemodialysis?
Extracorporeal unfractionated heparin during hemodialysis does not significantly alter hematological markers or most electrolytes, aside from an expected decrease in serum potassium.
Answers are grounded in this paper and cite their sources.
Supports hematological safety of extracorporeal heparin in hemodialysis; hypothesis-generating and requires randomized confirmation.
End-Stage renal disease is the final stage of chronic kidney disease (CKD), which can be managed by hemodialysis (HD), peritoneal dialysis, or renal transplantation. This study was conducted to investigate the changes in hematological and electrolyte markers that occur pre and post hemodialysis using unfractionated heparin (UFH) to prevent extracorporeal circuit clotting. Fifty patients with end stage renal failure (22 males, 28 females), aged between 15-78 years, maintained on long-term hemodialysis at the hemodialysis center in Sulaimani city during the period between February 20 th 2013 and July 15 th 2013 were enrolled in the present study. All patients provided written informed consent. The results of the hematological and electrolyte parameters measured pre and post hemodialysis were not significantly changed. No significant reduction in Hb level has been reported after dialysis compared to the pre-dialysis level. There were non-significant change in PTT, PT, and platelets count values in post-dialysis, which were not affected by the extracorporeal UFH. Although serum calcium and sodium levels were not significantly affected, serum potassium was significantly decreased in post hemodialysis states compared with pre-dialysis levels. This study revealed that extracorporeal use of UFH did not affect the hematological and electrolyte parameters post-dialysis in chronic renal failure patients maintained on hemodialysis. Only serum potassium was significantly decreased in post hemodialysis states, but still predictable fluctuations may limit the benefits of the procedure.
No takes yet. Share an insight, caveat, or question.
Ossman et al. (2014) conducted an observational in End-Stage renal disease (n=50). Extracorporeal unfractionated heparin (UFH) vs. Pre-dialysis baseline was evaluated on Changes in hematological and electrolyte markers pre and post hemodialysis. Extracorporeal use of unfractionated heparin during hemodialysis did not significantly affect hematological parameters, although serum potassium was significantly decreased post-dialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: